Assess whether related-party sales should be backed out of valuation (b0ca3b)

SITUATION Buy-side QoE lead in a health-system acquiring a specialty practice has one working extract — environmental known-condition schedule — after an earnout based on 'adjusted EBITDA' with no dictionary. If environmental known-condition schedule cannot support related-party sales should be, the only defensible M&A Due Diligence output is hold.

DECISION Buy-side QoE lead in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using environmental known-condition schedule after an earnout based on 'adjusted EBITDA' with no dictionary.

HYPOTHESES TO TEST 1. Environmental known-condition schedule reads as Proceed once an earnout based on 'adjusted EBITDA' with no dictionary is lined up to the same M&A Due Diligence population. 2. Environmental known-condition schedule is closer to Reprice after an earnout based on 'adjusted EBITDA' with no dictionary; Proceed would over-claim this Legal, IP, and Regulatory extract. 3. Walk is still live in environmental known-condition schedule for buy-side QoE lead in a health-system acquiring a specialty practice. 4. Environmental known-condition schedule is missing the fact buy-side QoE lead needs after an earnout based on 'adjusted EBITDA' with no dictionary; stop this M&A Due Diligence close.

ANALYSIS REQUIRED 1. Map reps, earnout mechanics, and integration risk a health-system acquiring a specialty practice would inherit. 2. Tie quality-of-earnings, working-capital, and contingent items in environmental known-condition schedule to related-party sales should be. 3. Name the document buy-side QoE lead still needs before signing. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read environmental known-condition schedule against an earnout based on 'adjusted EBITDA' with no dictionary and write the one fact that would move related-party sales should be for buy-side QoE lead.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (environmental known-condition schedule after an earnout based on 'adjusted EBITDA' with no dictionary). If environmental known-condition schedule cannot force a M&A Due Diligence label under Legal, IP, and Regulatory, stop. If environmental known-condition schedule after an earnout based on 'adjusted EBITDA' with no dictionary cannot support Proceed versus Reprice on this M&A Due Diligence Legal, IP, and Regulatory close, buy-side QoE lead must do not proceed, reprice, or walk on a quality-of-earnings fact the packet does not carry.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on related-party sales should be, then the evidence in environmental known-condition schedule, then the action for buy-side QoE lead - Hypothesis scorecard against environmental known-condition schedule: supported / rejected / untestable - Regulatory or exam hook Legal, IP, and Regulatory would cite - Legal, IP, and Regulatory finding in environmental known-condition schedule that a second reviewer can re-perform